NCT06789913 · Interventional trial
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
Overall registry status Recruiting
Phase 2
Conditions CLOVES Syndrome, Klippel Trenaunay Syndrome, Lymphatic Malformations, Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP), PIK3CA Mutation, PIK3CA-Related Overgrowth Spectrum (PROS), Vascular Anomalies, Vascular Malformations
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory